Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic
With the approval and distribution of demonstrably safe COVID-19 vaccines bearing exceptionally high efficacy profiles, it may be tempting to envision a return to “normal” in the coming months. However, if there is one lesson to be learned from the ongoing pandemic, it is that, in a world of evolvin...
Main Authors: | Ilham M. Alshiraihi, Gerald L. Klein, Mark A. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Diseases |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-9721/9/1/12 |
Similar Items
-
Structural basis of the monkeypox virus mRNA cap N7 methyltransferase complex
by: Anke Chen, et al.
Published: (2024-12-01) -
Cannabinoid-Inspired Inhibitors of the SARS-CoV-2 Coronavirus 2′-<i>O</i>-Methyltransferase (2′-<i>O</i>-MTase) Non-Structural Protein (Nsp10–16)
by: Menny M. Benjamin, et al.
Published: (2024-10-01) -
Protein methyltransferases /
by: Clarke, Steven G., et al.
Published: (2006) -
3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
by: Olga Bobileva, et al.
Published: (2023-01-01) -
Targeting Viral Methyltransferases: An Approach to Antiviral Treatment for ssRNA Viruses
by: Peter Ramdhan, et al.
Published: (2022-02-01)